Paradox Immunotherapeutics

Drug DiscoveryWebsite

Operator of a biotech company intended to develop a front-line monoclonal antibody treatment for protein misfolding diseases. The company provides the identification and development of specialized ant...

Drug Discovery
Healthcare
Toronto, Canada
Founded 2019
9 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$10M
Last Round
Accelerator/Incubator
Jan 2022
Latest Funding Round
Accelerator/Incubator
Jan 1, 2022
View all funding rounds
Investors
+9 other investors
View all 9 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Paradox Immunotherapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required